`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`IN THE UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`AMNEAL PHARMACEUTICALS LLC AND
`AMNEAL PHARMACEUTICALS OF NEW YORK, LLC,
`Petitioners,
`
`v.
`
`ALLERGAN, INC.,
`Patent Owner.
`
`Case No. IPR2018-00608
`Patent No. 9,161,926
`
`PATENT OWNER ALLERGAN, INC.’S
`MANDATORY NOTICES UNDER 37 C.F.R. § 42.8
`
` DC: 6653369-1
`
`
`
`
`
`IPR2018-00608
`
`Pursuant to 37 C.F.R. § 42.8, Patent Owner Allergan, Inc. submits the
`
`following Mandatory Notices. In accordance with 37 C.F.R. § 42.8(a)(2), these
`
`Mandatory Notices are being timely filed within 21 days of service of the petition.
`
`A. Real Party-In-Interest Under 37 C.F.R. § 42.8(b)(1)
`
`The real party-in-interest is Allergan, Inc. Allergan, Inc. is an indirect
`
`subsidiary of Allergan plc, a publicly traded company.
`
`B. Related Matters Under 37 C.F.R. § 42.8(b)(2)
`
`Patent Owner is not presently aware of any other proceedings involving U.S.
`
`Patent No. 9,161,926. The ’926 patent is the parent of continuation U.S. Patent
`
`No. 9,517,219, which is the subject of Allergan, Inc. v. Taro Pharmaceutical
`
`Industries Ltd. and Taro Pharmaceuticals, Inc., Civil Action No. 17-663 (VAC)
`
`(SRF) (Consol.) (D.Del.), filed June 1, 2017.
`
`C. Lead and Back-Up Counsel Under 37 C.F.R. § 42.8(b)(3)
`
`Lead Counsel
`Scott E. Kamholz (Reg. No. 48,543)
`skamholz@cov.com
`Postal and Hand-Delivery Address:
`Covington & Burling LLP
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001
`Phone: (202) 662-5339
`Fax: (202) 778-5339
`
`Back-Up Counsel
`Jessica L. Parezo (Reg. No. 50,286)
`jparezo@cov.com
`Postal and Hand-Delivery Address:
`Covington & Burling LLP
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001
`Phone: (202) 662-5498
`Fax: (202) 778-5498
`
`
`
`1
`
`
`
`
`
`IPR2018-00608
`
`D. Service Information Under 37 C.F.R. § 42.8(b)(4)
`
`Service information for lead and back-up counsel is provided in the
`
`designation of lead and back-up counsel, above. Service of any documents via hand-
`
`delivery may be made at the postal mailing address of the respective lead and back-
`
`up counsel designated above. Patent Owner Allergan, Inc. consents to electronic
`
`service by email at the above listed email addresses of lead and back-up counsel and
`
`at IPR2018-00608@cov.com.
`
`E.
`
`Power of Attorney
`
`A Power of Attorney to transact all business in the United States Patent and
`
`Trademark Office (“USPTO”) in connection with the above-referenced Inter Partes
`
`Review from Patent Owner Allergan, Inc. to the above-designated counsel at
`
`Covington & Burling LLP is being filed concurrently with these Mandatory Notices.
`
`The Power of Attorney is accompanied by a Statement Under 37 C.F.R. § 3.73(c),
`
`executed by the Patent Owner.
`
`Dated: Feb. 28, 2018
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
`By /Scott E. Kamholz, Reg. No. 48,543/
`Scott E. Kamholz, Reg. No.: 48,543
`Jessica L. Parezo, Reg. No.: 50,286
`COVINGTON & BURLING LLP
`One CityCenter, 850 Tenth Street, NW
`Washington, DC 20001
`(202) 662-6000
`Attorneys for Patent Owner
`
`2
`
`
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`Pursuant to 37 C.F.R. § 42.6, I hereby certify that the foregoing Patent Owner
`
`Allergan, Inc.’s Mandatory Notices Under 37 C.F.R. § 42.8 was served by electronic
`
`mail, on the following counsel of record for petitioner.
`
`
`
`Dennies Varughese (dvarughe-PTAB@skgf.com)
`Adam C. LaRock (alarock-PTAB@skgf.com)
`PTAB@skgf.com
`Sterne, Kessler, Goldstein & Fox
`1100 New York Avenue, NW
`Washington, DC 20005
`
`
`
`
`
`
`
`Date: Feb. 28, 2018
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
` /Scott E. Kamholz, Reg. No. 48,543/
`Scott E. Kamholz
`Registration No.: 48,543
`
`
`
`
`
`